Overview
Farmak International operates in the pharmaceutical sector, offering prescription medicines, over-the-counter medicines, dietary supplements and medical devices. Its communicated medicinal products include Dutilox and Levosimendan Farmak, and the company also participates in medical and pharmaceutical conferences.
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
News
Information regarding the medicinal product Dutilox
Announcement to professional healthcare workers dated 06-08-2026
Farmak International Poland statement regarding the drug Levosimendan
Announcement about the change of the Company's President
Farmak International participated as a partner in the National Pharmaceutical Conference Slawex 2025
Farmak International participated as a partner in the 44th Congress of the Polish Medical Radiological Society in Poznań
Industry
Bank accounts
Registered as a VAT taxpayer on 2003-12-31. Active
06 1050 1461 1000 0023 5664 8283
09 1140 1010 0000 5296 6400 1001- 40 1050 0086 1000 0090 3196 1163
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 166.2KPLN 166,153 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Feb 4, 2025 | Merger plan |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 17, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $897.5K$897,482 | Polski Fundusz Rozwoju S.A. |
Tenders
No recorded participation in tenders.
Public procurement disputes (KIO)
Farmak International has been a party to 2 cases before the National Appeal Chamber (since 2024). It filed 2 appeals (1 upheld).
Trademarks
Farmak International holds 109 active trademarks registered with the Polish Patent Office. 2 applications are pending. 20 marks have expired or were not registered. The first mark was filed in 2005.
| Mark | Protected until | |
|---|---|---|
| ASIL(word) | Nov 28, 2035 | |
| SIDAB(word) | Mar 13, 2035 | |
| MIGRAMOL(word) | Mar 13, 2035 | |
| Septogard plus | Mar 13, 2035 | |
| REGUBLO(word) | Mar 13, 2035 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
If the management board is a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Farmak Group Limited | 53,745 | $7,258,914.10 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aflofarm Farmacja Polskasp. z o.o. | $302,019,142.07 | aflofarm.pl | ||
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $160,174,284.28 | anpharm.pl | ||
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| Phytopharm KlękaS.A. | $46,154,888.31 | phytopharm.pl | ||
| VipharmS.A. | $30,660,173.61 | vipharm.pl | ||
| Przedsiębiorstwo Farmaceutyczne Farmapolsp. z o.o. | $21,462,728.43 | farmapol.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-01 | Share capital change (26,872,000.00 PLN → 26,872,500.00 PLN) | |
| 2025-04-01 | Name change ("symphar" → Farmak International) | |
| 2017-03-16 | Address change (Włoska 1, 00-777, Warszawa → Ul. Koszykowa 65, 00-667, Warszawa) | |
| 2015-07-23 | PKD change (Removed: 46.19.Z, 46.49.Z, 64.20.Z, 73.12.B, 73.12.C, 73.12.D, 85.59.B, 90.01.Z, 93.19.Z) | |
| 2013-02-21 | Share capital change (21,429,000.00 PLN → 26,872,000.00 PLN) |
FAQ
Last updated: 2026-10-07